News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
477,330 Results
Type
Article (29108)
Company Profile (128)
Press Release (448092)
Multimedia
Podcasts (89)
Webinars (14)
Section
Business (133819)
Career Advice (594)
Deals (22721)
Drug Delivery (101)
Drug Development (58477)
Employer Resources (58)
FDA (9712)
Job Trends (8461)
News (228185)
Policy (20470)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (4)
Academia (990)
Accelerated approval (40)
ADA (30)
Adcomms (11)
Allergies (155)
Alliances (36358)
ALS (153)
Alzheimer's disease (980)
Antibody-drug conjugate (ADC) (417)
Approvals (10260)
Artificial intelligence (514)
ASCO (248)
Autoimmune disease (287)
Automation (40)
Bankruptcy (200)
Best Places to Work (6267)
BIO (38)
BIOSECURE Act (9)
Biosimilars (193)
Biotechnology (59)
Bladder cancer (164)
Brain cancer (54)
Breast cancer (599)
Cancer (4626)
Cardiovascular disease (366)
Career advice (532)
Career pathing (16)
CAR-T (275)
CDC (18)
Celiac Disease (1)
Cell therapy (661)
Cervical cancer (38)
Clinical research (52454)
Collaboration (1665)
Commercialization (1)
Company closure (1)
Compensation (873)
Complete response letters (61)
COVID-19 (2263)
CRISPR (91)
C-suite (946)
Cystic fibrosis (107)
Data (6388)
Decentralized trials (1)
Denatured (20)
Depression (116)
Dermatology (70)
Diabetes (380)
Diagnostics (3310)
Digital health (34)
Diversity (5)
Diversity, equity & inclusion (16)
Drug discovery (255)
Drug pricing (144)
Drug shortages (20)
Duchenne muscular dystrophy (180)
Earnings (49896)
Editorial (29)
Employer branding (5)
Employer resources (54)
Events (78670)
Executive appointments (910)
FDA (12546)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (10)
Frontotemporal dementia (18)
Funding (1328)
Gene editing (175)
Generative AI (41)
Gene therapy (451)
GLP-1 (693)
Government (2429)
Grass and pollen (7)
Guidances (305)
Healthcare (7330)
Hematology (141)
HIV (66)
Huntington's disease (37)
IgA nephropathy (96)
Immunology and inflammation (196)
Immuno-oncology (77)
Indications (182)
Infectious disease (2507)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (99)
Intellectual property (220)
Interviews (86)
IPO (8994)
IRA (35)
Job creations (2557)
Job search strategy (467)
JPM (36)
Kidney cancer (16)
Labor market (44)
Layoffs (285)
Leadership (14)
Legal (4935)
Liver cancer (70)
Longevity (17)
Lung cancer (607)
Lymphoma (447)
Machine learning (37)
Management (20)
Manufacturing (795)
Marketing (3)
MASH (186)
Medical affairs (1)
Medical device (3984)
Medtech (4051)
Mergers & acquisitions (14679)
Metabolic disorders (1049)
mRNA (147)
Multiple sclerosis (158)
NASH (17)
Neurodegenerative disease (287)
Neuropsychiatric disorders (80)
Neuroscience (2098)
Neurotech (1)
NextGen: Class of 2026 (2657)
Non-profit (1131)
Now hiring (26)
Obesity (458)
Opinion (217)
Ovarian cancer (174)
Pain (194)
Pancreatic cancer (236)
Parkinson's disease (269)
Partnered (19)
Patents (441)
Patient recruitment (537)
Peanut (45)
People (47916)
Pharmaceutical (66)
Pharmacy benefit managers (24)
Phase 1 (15918)
Phase 2 (23132)
Phase 3 (17685)
Pipeline (7274)
Policy (186)
Postmarket research (1880)
Preclinical (6208)
Press Release (38)
Prostate cancer (253)
Psychedelics (28)
Radiopharmaceuticals (227)
Rare diseases (834)
Real estate (3747)
Recruiting (24)
Regulatory (17007)
Reports (20)
Research institute (1107)
Resumes & cover letters (73)
Rett syndrome (37)
RNA editing (19)
RSV (59)
Schizophrenia (124)
Series A (223)
Series B (250)
Service/supplier (3)
Sickle cell disease (93)
Special edition (14)
Spinal muscular atrophy (116)
Sponsored (22)
Startups (2844)
State (2)
Stomach cancer (9)
Supply chain (91)
Tariffs (77)
The Weekly (67)
Vaccines (723)
Venture capital (74)
Weight loss (271)
Women's health (86)
Worklife (4)
Date
Today (74)
Last 7 days (331)
Last 30 days (1638)
Last 365 days (20953)
2026 (11026)
2025 (21403)
2024 (21627)
2023 (22852)
2022 (30998)
2021 (33957)
2020 (31001)
2019 (21287)
2018 (16452)
2017 (22399)
2016 (23881)
2015 (28844)
2014 (22988)
2013 (19764)
2012 (20687)
2011 (20651)
2010 (18765)
Location
Africa (501)
Alabama (48)
Alaska (1)
Arizona (160)
Arkansas (11)
Asia (32059)
Australia (4649)
California (9520)
Canada (2863)
China (1171)
Colorado (434)
Connecticut (410)
Delaware (362)
Europe (70437)
Florida (1325)
Georgia (270)
Hawaii (3)
Idaho (24)
Illinois (863)
India (83)
Indiana (385)
Iowa (11)
Japan (504)
Kansas (103)
Kentucky (28)
Louisiana (28)
Maine (11)
Maryland (1010)
Massachusetts (6954)
Michigan (156)
Minnesota (407)
Mississippi (2)
Missouri (85)
Montana (13)
Nebraska (11)
Nevada (112)
New Hampshire (28)
New Jersey (2809)
New Mexico (13)
New York (2439)
North Carolina (1222)
North Dakota (7)
Northern California (4924)
Ohio (234)
Oklahoma (11)
Oregon (24)
Pennsylvania (1637)
Puerto Rico (24)
Rhode Island (27)
South America (810)
South Carolina (21)
Southern California (3700)
Tennessee (111)
Texas (1526)
United States (32988)
Utah (157)
Vermont (1)
Virginia (307)
Washington D.C. (58)
Washington State (750)
West Virginia (2)
Wisconsin (118)
Wyoming (1)
477,330 Results for "modra pharmaceuticals b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs
China’s Haisco Pharmaceutical continues to wield deals, this time out-licensing rights to two late-stage programs to New Jersey biotech Nuvectis.
June 22, 2026
·
2 min read
·
Gabrielle Masson
Job Trends
Ones to watch: 4 biotechs with recent Series B raises (that are also hiring)
Biopharmas that announced Series B financing this year and are looking for employees as they grow include two companies that received $100 million or more. One has partnerships with three Big Pharmas.
June 18, 2026
·
4 min read
·
Angela Gabriel
Deals
Lilly deepens relationship with China’s Abbisko for $1.9B biobucks
Lilly has already spent more than $25 billion in potential business development commitments this year, including the $6.3 billion buyout of Centessa Pharmaceuticals that closed today.
June 24, 2026
·
2 min read
·
Tristan Manalac
Artificial intelligence
Alnylam hops on AI train with up to $2B Inceptive partnership
Alnylam Pharmaceuticals will leverage Inceptive Nucleics’ generative machine learning models to accelerate the development of RNA interference therapies.
June 4, 2026
·
1 min read
·
Tristan Manalac
Policy
Modra Pharmaceuticals Announces U.S. Patent Issuance for ModraDoc006/r
Modra Pharmaceuticals announced that the U.S. Patent and Trademark Office has issued to Modra U.S. Patent No. 11,571,408, covering the use of its oral taxane therapeutic ModraDoc006/r. ModraDoc006/r is an oral tablet formulation of docetaxel co-administered with ritonavir, a boosting agent that enhances bioavailability.
March 16, 2023
·
2 min read
Press Releases
Reunion Neuroscience Announces Appointment of Sahil V. Kirpekar, M.D., as President and CEO
June 15, 2026
·
4 min read
Press Releases
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™
April 28, 2026
·
7 min read
Press Releases
RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.
December 15, 2025
·
3 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update
June 11, 2026
·
9 min read
Press Releases
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
October 20, 2025
·
2 min read
1 of 47,733
Next
